Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AbbVie Inc. (ABBV)

78.15   0.58 (0.75%) 04-22 16:01
Open: 77.6 Pre. Close: 77.57
High: 79.1 Low: 77.5
Volume: 5,201,200 Market Cap: 115518M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 79.137 - 79.615 79.615 - 80.073
Low: 76.391 - 76.953 76.953 - 77.491
Close: 77.241 - 78.066 78.066 - 78.858

Technical analysis

as of: 2019-04-22 4:24:17 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 95.43     One year: 98.96
Support: Support1: 76.81    Support2: 63.91
Resistance: Resistance1: 81.70    Resistance2: 84.73
Pivot: 81.35
Moving Average: MA(5): 78.98     MA(20): 81.05
MA(100): 83.26     MA(250): 89.99
MACD: MACD(12,26): -0.47     Signal(9): 0.10
Stochastic oscillator: %K(14,3): 10.62     %D(3): 12.21
RSI: RSI(14): 37.67
52-week: High: 107.25  Low: 75.77  Change(%): -16.2
Average Vol(K): 3-Month: 640558  10-Days: 514412

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ABBV has closed above bottom band by 10.1%. Bollinger Bands are 3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 20 Apr 2019 14:07:34 Z
3 Cancer Treatment Stocks to Buy in April

Thu, 18 Apr 2019 17:24:33 Z
AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?

Thu, 18 Apr 2019 17:12:39 Z
Can Q1 Earnings Lift Healthcare ETFs Higher?

Thu, 18 Apr 2019 16:25:10 Z
Here Are the Key Takeaways From J&J's Q1 Earnings Report

Wed, 17 Apr 2019 03:07:06 Z
Is TG Therapeutics a Buy?

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 1480.00
Shares Float (M) 1470.00
% Held by Insiders 0.09
% Held by Institutions 71.89
Shares Short (K) 22190
Shares Short P. Month (K)

Stock Financials

EPS 3.660
EPS Est. Current Year 5.530
EPS Est. Next Year 6.560
EPS Est. Next Quarter 1.440
Forward EPS 8.888
Book Value (p.s.) -5.710
PEG Ratio 0.98
Profit Margin 17.36
Operating Margin 36.37
Return on Assets (ttm) 11.4
Return on Equity (ttm)
Qtrly Rev. Growth 7.3
Gross Profit (p.s.) 16.919
Sales Per Share
EBITDA (p.s.) 9.243
Qtrly Earnings Growth
Operating Cash Flow (M) 13430.00
Levered Free Cash Flow (M) 12400.00

Stock Valuations

P/E 21.34
P/E Growth Ratio 0.01
P/BV -13.68
P/S 5439435264.00
P/CF 8.61

Dividends & Splits

Dividend 3.950
Dividend Yield 0.05
Dividend Pay Date 2019-05-15
Ex-Dividend Date 2019-04-12
Forward Dividend 4.280
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.